低冠心病可能性人群两种双嘧达莫输注方案的心肌灌注成像比较
该研究回顾性分析了147例低显著阻塞性冠心病可能性受试者,比较4分钟(0.56 mg·kg-1)与5分钟(0.70 mg·kg-1)双嘧达莫输注方案对负荷心肌血流量的影响。两组负荷MBF、心肌血流储备和冠脉血管阻力指数无显著差异,5分钟方案症状发生率更高且收缩压下降更明显。结论认为两种方案产生可比的心肌血流反应、血流动力学变化和症状。
要点
- 4分钟与5分钟双嘧达莫方案负荷MBF、MFR和CVRI无显著差异。
- 5分钟方案症状发生率92.7% vs 4分钟方案81.5%(P=0.04)。
- 5分钟方案收缩压下降-9 mmHg vs 4分钟方案-6 mmHg(P=0.03)。
核心结论
- 在低显著阻塞性冠心病可能性受试者中,4分钟与5分钟双嘧达莫输注方案产生可比的心肌血流反应、血流动力学变化和症状。
研究设计与样本
- 回顾性审查2207例接受铷-82 PET MPI患者的病历,纳入147例低显著CAD可能性受试者(钙化评分=0、BMI<45 kg·m-2、SSS≤3)。
- 65例采用4分钟双嘧达莫输注方案(0.56 mg·kg-1),82例采用5分钟方案(0.70 mg·kg-1)。
主要发现
- 负荷MBF在4分钟组为3.23±0.76 vs 5分钟组3.02±0.71 mL·min-1·g-1(P=0.09),无显著差异。
- 心肌血流储备在4分钟组为2.70±0.67 vs 5分钟组2.85±0.74(P=0.20),无显著差异。
- 冠脉血管阻力指数在4分钟组为30±10 vs 5分钟组31±9 mmHg×g×min·mL-1(P=0.38),无显著差异。
- 5分钟方案症状发生率92.7% vs 4分钟方案81.5%(P=0.04),5分钟方案更高。
- 5分钟方案收缩压下降-9 mmHg vs 4分钟方案-6 mmHg(P=0.03),5分钟方案下降更明显。
关键数值与推荐
- 低显著CAD可能性定义为钙化评分=0、BMI<45 kg·m-2、SSS≤3。
- 4分钟方案双嘧达莫剂量0.56 mg·kg-1,5分钟方案剂量0.70 mg·kg-1。
临床怎么用
- 在低显著阻塞性冠心病可能性人群中,4分钟与5分钟双嘧达莫输注方案的心肌血流反应、血流动力学变化和症状可比。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Myocardial perfusion imaging (MPI) with positron emission tomography allows accurate measurements of myocardial blood flow (MBF). Stress MBF thresholds have been proposed to provide diagnostic and prognostic information in different pathology. Most studies relying on dipyridamole use a 5-minute infusion protocol, while current guidelines recommend a 4-minute infusion. The purpose of this study is to compare the effects of different dipyridamole infusion times on stress MBF. METHODS: The charts of 2,207 patients who underwent rubidium-82 MPI were retrospectively reviewed and 147 subjects with low likelihood of significant coronary artery disease (CAD) defined as calcium score = 0, body mass index < 45 kg·m-2, and summed stress score ≤ 3 were included. Of those, 65 were imaged with a 4-minute dipyridamole infusion (0.56 mg·kg-1) protocol and 82 with a 5-minute protocol (0.70 mg·kg-1). RESULTS: Stress MBF (3.23±0.76 vs 3.02±0.71 mL·min-1·g-1, P = 0.09), myocardial flow reserve (2.70±0.67 vs 2.85±0.74, P = 0.20), and coronary vascular resistance index (30±10 vs 31±9 mmHg × g × min·mL-1, P = 0.38) were not significantly different between the two protocols. The 5-minute protocol was associated with higher prevalence of symptoms (92.7% vs 81.5%, P = 0.04) and greater decrease in systolic blood pressure (- 9 vs - 6 mmHg, P = 0.03). CONCLUSIONS: The 4-minute and 5-minute dipyridamole infusion protocols produce comparable myocardial flow response, hemodynamic changes, and symptoms, in subjects with low likelihood of significant obstructive CAD.
引用
- Harel F, Finnerty V, Authier S, et al. Comparison of two dipyridamole infusion protocols for myocardial perfusion imaging in subjects with low likelihood of significant obstructive coronary artery disease. J Nucl Cardiol. 2018. PMID: 30367380. doi:10.1007/s12350-018-01478-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。